Article
On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data
2026-04-24
Abstract excerpt
In the treatment of high grade serous ovarian cancer (HGSC), patients initially diagnosed with unresectable tumors are first treated with neoadjuvant chemotherapy (NACT) to reduce tumor burden prior to surgery. Analysis of matched pre- and post-NACT samples from the same patients enables the investigation of chemotherapy impacts and the biomarkers of progression. Although the tumor immune microenvironment (TIME) h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 481bc4da-a886-52be-ba30-f937ef471a37
- DOI
- 10.64898/2026.04.22.719856
